Shopping Cart
Remove All
Your shopping cart is currently empty
IKKβ-IN-3 (Compound hit4) is an IKKβ inhibitor with an IC50 value of 30.4 nM. It targets IKKβ, a crucial enzyme within the NF-κB signaling pathway, which plays a role in the development of various diseases. IKKβ-IN-3 can be utilized for research on CAF-induced arthritis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | IKKβ-IN-3 (Compound hit4) is an IKKβ inhibitor with an IC50 value of 30.4 nM. It targets IKKβ, a crucial enzyme within the NF-κB signaling pathway, which plays a role in the development of various diseases. IKKβ-IN-3 can be utilized for research on CAF-induced arthritis. |
| Targets&IC50 | IKKβ:30.4 nM |
| In vivo | IKKβ-IN-3 (Compound hit4) administered at doses of 10 and 30 mg/kg once daily for 14 days demonstrates anti-inflammatory effects in a complete Freund's adjuvant-induced arthritis (AIA) rat model. |
| Formula | C18H27NO4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.